Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Int J Obes (Lond) ; 39(4): 571-8, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25614087

RESUMEN

BACKGROUND: Obesity is associated with decreased iron status, possibly due to a rise in hepcidin, an inflammatory protein known to reduce iron absorption. In animals, we have shown that maternal iron deficiency is minimised in the foetus by increased expression of placental transferrin receptor (pTFR1), resulting in increased iron transfer at the expense of maternal iron stores. OBJECTIVE: This study examines the effect of obesity during pregnancy on maternal and neonatal iron status in human cohorts and whether the placenta can compensate for decreased maternal iron stores by increasing pTFR1 expression. SUBJECTS/METHODS: A total of 240 women were included in this study. One hundred and fifty-eight placentas (Normal: 90; Overweight: 37; Obese: 31) were collected at delivery. Maternal iron status was measured by determining serum transferrin receptor (sTFR) and ferritin levels at 24 and 34 weeks and at delivery. Hepcidin in maternal and cord blood was measured by ELISA and pTFR1 in placentas by western blotting and real-time RT-PCR. RESULTS: Low iron stores were more common in obese women. Hepcidin levels (ng ml(-1)) at the end of the pregnancy were higher in obese than normal women (26.03±12.95 vs 18.00±10.77, P<0.05). Maternal hepcidin levels were correlated with maternal iron status (sTFR r=0.2 P=0.025), but not with neonatal values. mRNA and protein levels of pTFR1 were both inversely related to maternal iron status. For mRNA and all women, sTFR r=0.2 P=0.044. Ferritin mRNA levels correlated only in overweight women r=-0.5 P=0.039 with hepcidin (r=0.1 P=0.349), irrespective of maternal body mass index (BMI). CONCLUSIONS: The data support the hypothesis that obese pregnant women have a greater risk of iron deficiency and that hepcidin may be a regulatory factor. Further, we show that the placenta responds to decreased maternal iron status by increasing pTFR1 expression.


Asunto(s)
Antígenos CD/sangre , Hepcidinas/sangre , Hierro/sangre , Madres , Obesidad Abdominal/sangre , Placenta/metabolismo , Receptores de Transferrina/sangre , Adulto , Péptidos Catiónicos Antimicrobianos/sangre , Biomarcadores/sangre , Índice de Masa Corporal , Carbohidratos de la Dieta/efectos adversos , Sacarosa en la Dieta/efectos adversos , Femenino , Homeostasis , Humanos , Recién Nacido , Deficiencias de Hierro , Hierro de la Dieta/administración & dosificación , Masculino , Fenómenos Fisiologicos Nutricionales Maternos , Intercambio Materno-Fetal , Obesidad/sangre , Obesidad Abdominal/epidemiología , Obesidad Abdominal/prevención & control , Embarazo , Transferrina/metabolismo
2.
Br J Nutr ; 104(1): 83-92, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20205964

RESUMEN

Obesity is associated with complications during pregnancy and increased health risks in the newborn. The objective of the present study was to establish possible relationships between gut microbiota, body weight, weight gain and biochemical parameters in pregnant women. Fifty pregnant women were classified according to their BMI in normal-weight (n 34) and overweight (n 16) groups. Gut microbiota composition was analysed by quantitative real-time PCR in faeces and biochemical parameters in plasma at 24 weeks of pregnancy. Reduced numbers of Bifidobacterium and Bacteroides and increased numbers of Staphylococcus, Enterobacteriaceae and Escherichia coli were detected in overweight compared with normal-weight pregnant women. E. coli numbers were higher in women with excessive weight gain than in women with normal weight gain during pregnancy, while Bifidobacterium and Akkermansia muciniphila showed an opposite trend. In the whole population, increased total bacteria and Staphylococcus numbers were related to increased plasma cholesterol levels. Increased Bacteroides numbers were related to increased HDL-cholesterol and folic acid levels, and reduced TAG levels. Increased Bifidobacterium numbers were related to increased folic acid levels. Increased Enterobacteriaceae and E. coli numbers were related to increased ferritin and reduced transferrin, while Bifidobacterium levels showed the opposite trend. Therefore, gut microbiota composition is related to body weight, weight gain and metabolic biomarkers during pregnancy, which might be of relevance to the management of the health of women and infants.


Asunto(s)
Bacterias/aislamiento & purificación , Biomarcadores/sangre , Peso Corporal , Colon/microbiología , Sobrepeso/etiología , Complicaciones del Embarazo/etiología , Aumento de Peso , Adulto , Índice de Masa Corporal , Colesterol/sangre , HDL-Colesterol/sangre , Heces/microbiología , Femenino , Ferritinas/sangre , Ácido Fólico/sangre , Humanos , Lípidos/sangre , Sobrepeso/sangre , Embarazo , Complicaciones del Embarazo/sangre , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transferrina/metabolismo , Triglicéridos/sangre
3.
Nutr Hosp ; 23(6): 584-90, 2008.
Artículo en Español | MEDLINE | ID: mdl-19132267

RESUMEN

BACKGROUND: Maternal genetics and feeding before and during pregnancy, different maternal metabolic pathologies, as well as nutrient intakes of newborns in their first months of life may be involved in the obesity aetiology and its long-term consequences. The possible role of these and others factors, the mechanisms and the effects on the metabolism, and the development of this disease need further research. OBJECTIVE: To acquire more knowledge about foetal adipose tissue development and the influence of genetic, dietetic and environmental factors on the risk to suffer from obesity. METHODOLOGY: Four study groups have been established with 30 pregnant women in each one: 1) control group; 2) mothers with glucose intolerance/gestational diabetes; 3) women with low weight gain during pregnancy, and 4) women with overweight/obesity at the beginning of the pregnancy. The magnitudes to be studied are: 1) dietary intake; 2) life-style habits; 3) physical activity; 4) anthropometry and body composition; 5) haematological study; 6) biochemical study (lipid and metabolic biomarkers); 7) immune function profile related to nutritional status; 8) psychological profile; 9) genetic biomarkers, and 10) microbiological markers; all of them in relation to the development of the foetal adipose tissue in the first stages of life and the risk of suffering from obesity in the future. CONCLUSION: This project, coordinated by the Department of Paediatrics of the School of Medicine in the University of Granada, and with the collaboration of well-known and expert research groups, tries to contribute to the knowledge about the obesity aetiology in infancy and its subsequent development in later periods of life.


Asunto(s)
Tejido Adiposo/embriología , Desarrollo Fetal/genética , Fenómenos Fisiologicos de la Nutrición Prenatal , Adolescente , Adulto , Femenino , Humanos , Persona de Mediana Edad , Embarazo , Adulto Joven
4.
J Clin Endocrinol Metab ; 101(1): 59-68, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26513002

RESUMEN

CONTEXT: Maternal obesity and gestational diabetes mellitus (GDM) can both contribute to adverse neonatal outcomes. The extent to which this may be mediated by differences in placental metabolism and nutrient transport remains to be determined. OBJECTIVE: Our objective was to examine whether raised maternal body mass index (BMI) and/or GDM contributed to a resetting of the expression of genes within the placenta that are involved in energy sensing, oxidative stress, inflammation, and metabolic pathways. METHODS: Pregnant women from Spain were recruited as part of the "Study of Maternal Nutrition and Genetics on the Foetal Adiposity Programming" survey at the first antenatal visit (12-20 weeks of gestation) and stratified according to prepregnancy BMI and the incidence of GDM. At delivery, placenta and cord blood were sampled and newborn anthropometry measured. RESULTS: Obese women with GDM had higher estimated fetal weight at 34 gestational weeks and a greater risk of preterm deliveries and cesarean section. Birth weight was unaffected by BMI or GDM; however, women who were obese with normal glucose tolerance had increased placental weight and higher plasma glucose and leptin at term. Gene expression for markers of placental energy sensing and oxidative stress, were primarily affected by maternal obesity as mTOR was reduced, whereas SIRT-1 and UCP2 were both upregulated. In placenta from obese women with GDM, gene expression for AMPK was also reduced, whereas the downstream regulator of mTOR, p70S6KB1 was raised. CONCLUSIONS: Placental gene expression is sensitive to both maternal obesity and GDM which both impact on energy sensing and could modulate the effect of either raised maternal BMI or GDM on birth weight.


Asunto(s)
Peso Corporal , Diabetes Gestacional/fisiopatología , Placenta/fisiopatología , Resultado del Embarazo , Adolescente , Adulto , Antropometría , Peso al Nacer/genética , Índice de Masa Corporal , Diabetes Gestacional/genética , Ingestión de Energía/genética , Femenino , Expresión Génica/genética , Intolerancia a la Glucosa/complicaciones , Intolerancia a la Glucosa/genética , Humanos , Recién Nacido , Inflamación/genética , Inflamación/patología , Estudios Longitudinales , Redes y Vías Metabólicas/genética , Persona de Mediana Edad , Obesidad/complicaciones , Obesidad/genética , Estrés Oxidativo , Placenta/metabolismo , Embarazo , España/epidemiología , Adulto Joven
5.
Med. interna Méx ; 33(5): 612-617, sep.-oct. 2017. graf
Artículo en Español | LILACS | ID: biblio-894303

RESUMEN

Resumen ANTECEDENTES: Malassezia spp es un saprófito de la piel, relacionada con diversas afecciones cutáneas, se ha reportado frecuencia elevada en pacientes con inmunosupresión. OBJETIVO: determinar la prevalencia de Malassezia spp en individuos con diabetes mellitus tipo 2 de acuerdo con el control glucémico. MATERIAL Y MÉTODO: estudio abierto, observacional, descriptivo y transversal, efectuado en pacientes voluntarios que participaron en la 24ª Carrera Nacional del Paciente con Diabetes el 15 de octubre de 2016 en la Ciudad de México, en quienes se realizó toma de glucemia capilar preprandial y hemoglobina glicosilada, así como pesquisa de Malassezia spp mediante frotis de la región malar, teñido con azul de metileno. RESULTADOS: se incluyeron 49 pacientes con diabetes mellitus tipo 2; hubo predominio de 31 pacientes sin buen control glucémico (67%) en comparación con 16 pacientes controlados (33%). Los frotis con levaduras escasas (+) estuvieron presentes en 21 (59%) pacientes sin control y en 7 (41%) pacientes con control; los frotis con cantidad de levaduras moderada (++) se observaron en 7 (74%) pacientes sin control y en 5 (26%) pacientes con control; los frotis con levaduras abundantes estuvieron presentes en 7 (63%) pacientes sin control y en 2 (37%) pacientes con control. CONCLUSIÓN: en nuestro estudio la prevalencia de Malassezia spp en pacientes con diabetes mellitus tipo 2 fue del 100%, con menor número de levaduras en los que tenían control glucémico adecuado, lo que puede indicar que la posibilidad de tener esta levadura aumenta con el descontrol glucémico y probablemente denota el grado de inmunosupresión en estos pacientes.


Abstract BACKGROUND: Malassezia spp is a saprophyte of the skin, related to diverse cutaneous affections, and has been reported a high frequency in patients with immunosuppression. OBJECTIVE: To determine the prevalence of Malassezia spp in individuals with type 2 diabetes mellitus according to glycemic control. MATERIAL AND METHOD: An open, observational, descriptive and cross-sectional study was performed in volunteer patients who participated in the 24th National March of the Patient with Diabetes in Mexico City on October 15, 2016; where preprandial capillary glycemia and glycosylated hemoglobin were taken. We took a scraping of the malar region skin to find Malassezia spp, smears stained with methylene blue. RESULTS: A total of 49 patients with type 2 diabetes mellitus were included; there were a predominance of 31 patients without glycemic control (67%) in comparison with 16 controlled patients (33%). Smears with low yeast (+) were present in 21 (59%) uncontrolled patients and in 7 (41%) controlled patients; smears with a moderate amount of yeast (++) were present in 7 (74%) uncontrolled patients and in 5 (26%) controlled patients; smears with abundant yeasts were present in 7 (63%) uncontrolled patients and in 2 (37%) controlled patients. CONCLUSION: In our study the prevalence of Malassezia spp in patients with type 2 diabetes mellitus was of 100%, with a lower number of yeasts in patients with adequate glycemic control; this can indicate that the possibility of presenting this yeast increases with bad glycemic control and probably denotes the degree of immunosuppression in these patients.

6.
Nutr. hosp ; 23(6): 584-590, nov.-dic. 2008.
Artículo en Español | IBECS (España) | ID: ibc-76655

RESUMEN

Introducción: La genética y la alimentación de la madre antes y durante el embarazo, las distintas patologías metabólicas maternas, así como la ingesta de nutrientes en los primeros meses de vida del recién nacido parecen estar implicados en la etiología de la obesidad y sus consecuencias a largo plazo. La posible contribución de estos y otros factores, los mecanismos y sus efectos en el metabolismo y desarrollo de la enfermedad están aún en fase de investigación. Objetivo: Obtener un mayor conocimiento del desarrollo del tejido adiposo fetal y la influencia de factores genéticos, dietéticos y ambientales sobre el riesgo a largo plazo de padecer obesidad. Metodología: Se han establecido cuatro grupos de estudio de 30 madres gestantes cada uno: 1) grupo control; 2) madres con intolerancia a la glucosa/diabetes gestacional; 3) madres con escasa ganancia ponderal durante el embarazo, y 4) madres con sobrepeso/obesidad al inicio del embarazo. Se realizará un análisis de los siguientes parámetros: 1) ingesta dietética; 2) hábitos y estilo de vida; 3) actividad física; 4) antropometría y composición corporal; 5) estudio hematológico; 6) estudio bioquímico (biomarcadores lipídicos y metabólicos); 7) perfil inmunológico; 8) perfil psicológico; 9) marcadores genéticos, y 10) marcadores microbiológicos; todos ellos relacionados con la formación del tejido adiposo fetal en las primeras etapas de la vida y el riesgo de padecer obesidad en el futuro. Conclusión: En este proyecto, coordinado por el Departamento de Pediatría de la Facultad de Medicina de la Universidad de Granada y que cuenta con la participación de otros grupos de investigación de larga y acreditada experiencia, se pretende obtener un mayor conocimiento de los orígenes de la obesidad en la infancia y posterior desarrollo de esta enfermedad en etapas posteriores de la vida (AU)


Background: Maternal genetics and feeding before and during pregnancy, different maternal metabolic pathologies, as well as nutrient intakes of newborns in their first months of life may be involved in the obesity aetiology and its long-term consequences. The possible role of these and others factors, the mechanisms and the effects on the metabolism, and the development of this disease need further research. Objective: To acquire more knowledge about foetal adipose tissue development and the influence of genetic, dietetic and environmental factors on the risk to suffer from obesity. Methodology: Four study groups have been established with 30 pregnant women in each one: 1) control group; 2) mothers with glucose intolerance/gestational diabetes; 3) women with low weight gain during pregnancy, and 4) women with overweight/obesity at the beginning of the pregnancy. The magnitudes to be studied are: 1) dietary intake; 2) life-style habits; 3) physical activity; 4) anthropometry and body composition; 5) haematological study; 6) biochemical study (lipid and metabolic biomarkers); 7) immune function profile related to nutritional status; 8) psychological profile; 9) genetic biomarkers, and 10) microbiological markers; all of them in relation to the development of the foetal adipose tissue in the first stages of life and the risk of suffering from obesity in the future. Conclusion: This project, coordinated by the Department of Paediatrics of the School of Medicine in the University of Granada, and with the collaboration of well-known and expert research groups, tries to contribute to the knowledge about the obesity aetiology in infancy and its subsequent development in later periods of life (AU)


Asunto(s)
Humanos , Femenino , Embarazo , Adolescente , Adulto , Persona de Mediana Edad , Fenómenos Fisiologicos de la Nutrición Prenatal , Tejido Adiposo/embriología , Desarrollo Fetal/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA